Code
|
8121A
|
MA number
|
EU/1/09/544/003
|
Product Form:
|
sol inj 2x200 mg/1 ml (striek.inj.napl. s chrán.ihly+2 lieh.tamp.)
|
MA Status:
|
E - Valid centralised marketing authorisation
|
Type of procedure:
|
EU
|
MAH, country:
|
UCB Pharma S.A. , Belgium
|
Therapeutic Class:
|
29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
|
ATC:
|
L |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
L04 |
Immunosuppressants |
L04A |
Immunosuppressants |
L04AB |
Tumor necrosis factor alpha (TNF-alpha) inhibitors |
L04AB05 |
Certolizumab pegol |
|
Shelf life:
|
24 |
Container:
|
glass pre-filled syringe
|
Route of admin.:
|
Subcutaneous use
|